Short Interest in Hypera S.A. (OTCMKTS:HYPMY) Grows By 47.7%

Hypera S.A. (OTCMKTS:HYPMY) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 16,400 shares, an increase of 47.7% from the June 15th total of 11,100 shares. Based on an average trading volume of 15,400 shares, the days-to-cover ratio is presently 1.1 days.

Hypera Price Performance

Shares of OTCMKTS HYPMY traded up $0.25 during midday trading on Monday, reaching $5.44. 2,800 shares of the company traded hands, compared to its average volume of 26,160. Hypera has a 52 week low of $5.04 and a 52 week high of $9.43. The stock has a 50-day moving average price of $5.49 and a 200 day moving average price of $6.18.

Hypera (OTCMKTS:HYPMY) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.12 EPS for the quarter. The business had revenue of $368.97 million during the quarter.

Hypera Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.